Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Experimental OTC Cream for Atopic Dermatitis
NCT03386032Phase 3Completed
- Sponsor
- Procter & Gamble
- Start
- Nov 2017
- Primary completion
- Aug 2018
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of Investigational OTC Cream in atopic dermatitis (AD), sponsored by Procter & Gamble. Started Nov 2017; status: completed.
02
Drugs
Investigational OTC Cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03386032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03386032.